BioPharma

03 August, 2026 | Monday | Expert Insight

Advancing Freeze-to-Store Workflows for the Next Era of Biopharmaceutical Manufacturing

As biologics, biosimilars, and advanced cell and gene therapies continue to reshape the Asia-Pacific biopharmaceutical landscape, manufacturers are under increasing pressure to enhance cold ch...

Lab

04 August, 2026 | Tuesday | Analysis

10 Bioprocessing Bottlenecks and How APAC Plants Are Clearing Them

How this list was built Ten bottlenecks were identified from facility interviews, technical sessions at regional bioprocessing conferences and published case studies. Each entry pairs a constraint with...

BioTech

04 August, 2026 | Tuesday | Interaction

From Market Access to Long-Term Growth: Rethinking Biopharma Expansion in APAC

BioPharma APAC speaks with Girisan Kariangal, Regional Vice President – Business Development & Alliance Management, Menarini Asia-Pacific, on the evolving opportunities and challenges of expanding acr...

Contract Services

24 July, 2026 | Friday | News

Samsung Bioepis Secures Exclusive Commercial Rights to Nectin-4 ADC Candidate SBE303

Ÿ   Under the agreement, Samsung Bioepis will obtain exclusive commercial licensing rights to SBE303, an ADC candidate currently in joint development Ÿ   This agreement ...

Consumer Health

28 July, 2026 | Tuesday | News

Roche Secures US FDA Clearance for PCR Test Detecting Bacterial Vaginosis and Candida Vaginitis

The new PCR test uses clinician-collected or clinician-instructed, self-collected vaginal swab specimens to simultaneously detect organisms associated with Bacterial vaginosis (BV) and Candida ...

Medtech

28 July, 2026 | Tuesday | News

Advita Introduces Activit-E Vitamin E Polyethylene to Equinoxe Reverse Shoulder System

Advita Ortho, a global medical technology leader,  announced the first clinical use of humeral liners manufactured with Activit-E® polyethylene, bringing its advanced vitamin E polyethylene technology ...

Cell & Gene

03 August, 2026 | Monday | News

CellOrigin Advances In Vivo Cell Therapy Pipeline with ASCO Data and Walvax Partnership

CellOrigin, a biotechnology company focused on next-generation in vivo and in vitro cell therapy technologies, has announced two major progresses in both research and strategic partnership. At the 2026 AS...


Biopharma APAC Infomercial

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close